Apr. 16 at 2:47 PM
$INSM As of April 2026, Vanguard Group Inc. has not sold out of its position in Insmed Inc.; rather, it remains one of the company's largest institutional shareholders.
Current Holding Status: Recent filings from April 2026 indicate that Vanguard owns approximately 19.94 million shares of Insmed, valued at roughly
$2.87 billion.
Recent Activity: Instead of selling out, Vanguard reportedly increased its holdings by 13% (an addition of over 2.2 million shares) in the most recently reported cycles.
Major Stake: Vanguard holds approximately 9.76% to 10.07% of Insmed's total outstanding shares.
Internal Realignment: On January 12, 2026, Vanguard underwent an internal restructuring where certain subsidiaries began reporting their beneficial ownership separately. This change in reporting structure does not mean Vanguard sold the stock, but rather that the shares are managed across its newly established Vanguard Capital Management and Vanguard Portfolio Management units.
